Shareholder alert: levi & korsinsky, llp announces an investigation involving possible securities laws violations by the board of revance therapeutics, inc.

New york--(business wire)--levi & korsinsky announces it has commenced an investigation of revance therapeutics, inc. (“revance”) (nasdaq:rvnc) concerning possible violations of federal securities laws. the investigation concerns whether certain statements made in its registration statement issued in connection with its june 19, 2014 follow-on public stock offering were false and/or misleading and/or omitted material facts. to obtain additional information go to: http://zlk.9nl.com/revance-therapeutics-rvnc or contact joseph e. levi, esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972. there is no cost or obligation to you. levi & korsinsky is a national firm with offices in new york, new jersey, connecticut and washington d.c. the firm’s attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. attorney advertising. prior results do not guarantee similar outcomes.
RVNC Ratings Summary
RVNC Quant Ranking